GGrantIndex
← Search

Development of Anti-Ebola MHC Tetramers to Evaluate Vaccines

$200,000Y01FY2011AINIH

National Institute Of Allergy And Infectious Diseases

Investigators

Abstract

This IAA supports the development of anti-Ebola MHC tetramers as a surrogate marker to evaluate cell mediated immunity in vaccines.

View original record on NIH RePORTER →